Abstract:Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide due to the lack of effective therapy methods. Therefore, there is an urgent need to develop novel therapies for HCC. CBL0137 is a small molecule that affects p53 and nuclear factor-kappa B (NF-κB). The expression of p53 was measured by using immunohistochemistry (IHC) in tumor and adjacent tissues. Western blotting (WB) and quantitative real-time polymerase chain reaction (qRT-PCR) were employed to detect the level of p-p53, p53, Bax, and PUMA after CBL0137 administration. CCK-8 and immunofluorescence staining (IF) assays were performed to evaluate the proliferation and viability of HCC cells. Flow cytometry was used to detect the apoptosis of HCC cells. Xenograft model was established to determine the effect of CBL0137 treatment on HCC tumor growth in vivo. HE staining was used to monitor HCC cell morphology and IHC staining for Ki-67 was performed to determine the tumor cell proliferation following CBL0137 treatment. Results showed that the expression of p-p53, p53, Bax, and PUMA was upregulated after CBL0137 administration. The viability, growth, and colony formation of HCC cells were significantly inhibited by CBL0137 in the CBL group compared with the NC group (p<0.05). Meanwhile, the results revealed that the proportions of apoptotic and necrotic cells were significantly elevated in the CBL group compared to the NC group (p<0.05). And the apoptosis-related proteins including PARP, caspase-3, caspase-7, caspase-8, and caspase-9 were increased in the CBL group compared with the NC group (p<0.05), while the NF-κB, p-NF-κB and p-AKT expression levels were significantly downregulated following CBL0137 treatment (p<0.05). Additionally, the tumor volume and weight were significantly reduced in the CBL group compared with the NC group (p<0.05). Moreover, HE staining and IHC staining for Ki-67 indicated that CBL0137 treatment could obviously induce cell apoptosis and suppress cell proliferation. CBL0137 treatment could effectively inhibit HCC cell proliferation and induce cell apoptosis associated with multiple factors expression.

Bile acids affect the growth of human cholangiocarcinoma via NF-kB pathway.

Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells.

Impact of Bile Acids on the Growth of Human Cholangiocarcinoma Via FXR

Betulinic acid induces apoptosis of gallbladder cancer cells via repressing SCD1.

Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma

Bile acid induces MUC2 expression and inhibits tumor invasion in gastric carcinomas

Deoxycholic acid modulates the progression of gallbladder cancer through N6-methyladenosine-dependent microRNA maturation

A high bile acid environment promotes apoptosis and inhibits migration in pancreatic cancer

Effects of specific bile acids on c-fos messenger RNA levels in human colon carcinoma Caco-2 cells

Bile Acids Modified by the Intestinal Microbiota Promote Colorectal Cancer Growth by Suppressing CD8+ T Cell Effector Functions

Expression of pGSK-3α/β (Tyr279/216) and XIAP proteins in cholangiocarcinoma and their clinical significance

Overexpressions of Ck2 Beta and Xiap Are Associated with Poor Prognosis of Patients with Cholangiocarcinoma

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Overexpressions of CK2β and XIAP Are Associated with Poor Prognosis of Patients with Cholangiocarcinoma

Taurolithocholic acid promotes intrahepatic cholangiocarcinoma cell growth via muscarinic acetylcholine receptor and EGFR/ERK1/2 signaling pathway

Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development

Primary bile acid activates Egr‑1 expression through the MAPK signaling pathway in gastric cancer

Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment

Hydroxytyrosol Inhibits Cholangiocarcinoma Tumor Growth: an in Vivo and in Vitro Study

Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis

Bile Acid Metabolomics Identifies Chenodeoxycholic Acid As a Therapeutic Agent for Pancreatic Necrosis.